Company Filing History:
Years Active: 2022-2025
Title: Cecilia Cotta-Ramusino: Innovator in Genome Editing
Introduction
Cecilia Cotta-Ramusino is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of genome editing, holding a total of 8 patents. Her work focuses on advancing techniques that enhance the precision and effectiveness of genetic modifications.
Latest Patents
Cotta-Ramusino's latest patents include innovative systems and methods for modulating chromosomal rearrangements. This patent addresses the modulation of chromosomal rearrangements, such as translocations, during genome editing. It aims to reduce unwanted chromosomal rearrangements while increasing the occurrence of desired ones. Another notable patent involves compositions and methods for promoting homology-directed repair (HDR). This application outlines improved methods of genome editing using Cas9 molecules to create breaks in genomic regions of interest. By bringing a template nucleic acid close to the break, the likelihood of repair through HDR is significantly enhanced.
Career Highlights
Cecilia Cotta-Ramusino is currently associated with Editas Medicine, Inc., a company at the forefront of genome editing technology. Her work has been instrumental in developing cutting-edge solutions that push the boundaries of genetic research and therapy.
Collaborations
Cotta-Ramusino collaborates with esteemed colleagues, including Anne Helen Bothmer and Hariharan Jayaram. These partnerships foster a dynamic environment for innovation and discovery in the realm of genetic engineering.
Conclusion
Cecilia Cotta-Ramusino is a trailblazer in the field of genome editing, with a strong portfolio of patents that reflect her commitment to advancing genetic research. Her contributions are paving the way for future innovations in this critical area of science.